Licensing Medicines - From Concept to Launch

Natasha Long is an experienced regulatory affairs specialist and consultant at Fusion Pharma, a UK-based pharmaceutical consultancy dedicated to supporting companies through every stage of the regulatory process. With more than two decades of experience in regulatory affairs, Natasha has become a trusted advisor to organisations seeking to bring medicinal products to market and maintain compliance in an increasingly complex regulatory sector.

Fusion Pharma delivers tailored regulatory support including regulatory strategy, licence submissions, regulatory intelligence, compliance strategy, ongoing maintenance of UK and EU marketing authorisations and PIL user testing. The organisation is known for its ability to simplify regulatory pathways and provide clear, pragmatic direction to clients ranging from emerging pharmaceutical companies to established Licence Holders.

Natasha’s expertise spans complex regulatory strategy, dossier management, product lifecycle oversight, and liaison with regulatory authorities. Her ability to anticipate regulatory challenges and guide clients through them makes her particularly valuable in environments where timelines, resources and compliance demands must be balanced carefully.

At the UK GDP Association’s 2026 Annual Conference, taking place on 16-17 June at Mercure Hotel, Northampton, Natasha will be explaining medicinal products “Licensing Medicines - From Concept to Launch” to delegates in her session on Day 1 of the conference.

Conference tickets are available now, book your in-person or virtual conference and charity dinner tickets here. UK GDP Association full members benefit from up to £100 discount on the cost of conference tickets so sign up today for just £29 + VAT per year!